Shahid Saba, Zaidi Samreen, Ahmed Shariq, Siddiqui Saima, Abid Aiysha, Malik Shabbir, Shamsi Tahir
Department of Genomics and Clinical Genetics, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan.
Department of Pediatrics, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan.
Front Genet. 2019 Apr 24;10:360. doi: 10.3389/fgene.2019.00360. eCollection 2019.
Leukocyte adhesion deficiency-III (LAD3) is an extremely rare primary immunodeficiency disorder, transmitted with autosomal-recessive inheritance. It is caused by genetic alteration in the gene, which leads to abnormal expression of kindlin-3. This cytoplasmic protein is highly expressed in leukocytes and platelets, and acts as an important regulator of integrin activation. LAD3 has features like bleeding syndrome of Glanzmann-type and leukocyte adhesion deficiency. mutation(s) have not been well characterized in Pakistani patients with LAD3. In this study, an infant and his family of Pakistani origin, presenting with clinical features of LAD, were investigated to determine the underlying genetic defect. Targeted next generation sequencing (TGS) and Sanger sequencing were performed to identify and confirm the causative mutations, respectively, and their segregation within the family. A novel, homozygous nonsense mutation (c.286C > T, p.Q96) was found in the proband, and its co-segregation with LAD3 phenotype within the family was consistent with an autosomal recessive inheritance. Both parents were carriers of the same mutation. This family was offered prenatal diagnosis during first trimester of the subsequent pregnancy; the fetus carried the variant. In conclusion, our study is the first report to identify the novel homozygous variant c.286C > T, p.Q96in the gene, which might be the causative mutation for LAD3 patients of Pakistani origin.
白细胞黏附缺陷-III型(LAD3)是一种极其罕见的原发性免疫缺陷病,呈常染色体隐性遗传。它由该基因的遗传改变引起,导致Kindlin-3表达异常。这种细胞质蛋白在白细胞和血小板中高表达,是整合素激活的重要调节因子。LAD3具有类似Glanzmann型出血综合征和白细胞黏附缺陷的特征。在巴基斯坦LAD3患者中,尚未对相关突变进行充分表征。在本研究中,对一名具有LAD临床特征的巴基斯坦裔婴儿及其家族进行了调查,以确定潜在的遗传缺陷。分别进行了靶向二代测序(TGS)和桑格测序,以识别和确认致病突变及其在家族中的分离情况。在先证者中发现了一个新的纯合无义突变(c.286C>T,p.Q96),其在家族中与LAD3表型的共分离符合常染色体隐性遗传。父母双方均为该突变的携带者。在随后妊娠的头三个月为这个家庭提供了产前诊断;胎儿携带该变异。总之,我们的研究是首次报告在该基因中鉴定出新的纯合变异c.286C>T,p.Q96,这可能是巴基斯坦裔LAD3患者的致病突变。